You can narrow down the results using the filters
This document provides information on the scope of changes which may be made to a genetically modified organism (GMO) licence after the licence has been issued, and outlines the Gene Technology Regulator’s (the Regulator’s) approach to considering applications to vary conditions of a GMO licence.
This application form is for dealings (activities) involving the release of GM plants into the environment that would not qualify as a limited and controlled release.
The quarterly activities include details of monitoring and compliance activities by the Office of the Gene Technology Regulator (OGTR) during the quarter.
The report describes the roles and responsibilities of the Gene Technology Regulator (the Regulator) and the Office of the Gene Technology Regulator (OGTR).
In order to assess the risks from the GMO the Regulator requires information about the GMO and the proposed work. While the applicant may want to keep some of this information secret, they must tell the Regulator so the right licence decision can be made.
This document describes how the potential risks of plant genetic modification (plant transformation) are considered when preparing Risk Assessment and Risk Management Plans (RARMPs).
The Regulator is an independent statutory office holder who administers the Act and has powers under the Act to monitor for compliance, and to take enforcement action when required.
In 2014 the Gene Technology Regulator (the Regulator) approved a trial of an oral live genetically modified cholera vaccine. Up to 1000 people were given a dose of the vaccine in a drink.
Use this form to apply for a declaration that specified information is confidential commercial information (CCI) under the Gene Technology Act 2000.
Gene technology (also known as genetic engineering or genetic modification) provides ways to make changes to genes – the sets of instructions in the cells of all living creatures. There is a large amount of overlap between ‘gene technology’ and the newer term ‘synthetic biology’.
This update outlines the work of the Office of the Gene Technology Regulator (OGTR) in ensuring compliance with Australia’s gene technology legislation and regulations.
These guidelines contain the requirements and conditions for certification of a Physical Containment Level 2 (PC2) Large Scale Facility issued pursuant to section 90 of the Gene Technology Act 2000 (the Act).
Checklist for annual inspection against the usual Conditions of Certification of the Gene Technology Regulator’s Guidelines for Certification of a Physical Containment Level 2 Large Scale Facility
Checklist against the requirements of the Gene Technology Regulator’s Guidelines for Certification of a Physical Containment Level 2 Large Scale Facility.